RDY | Dr. Reddy's Laboratories Ltd
Category: Pharmaceutical company
Industry: Drug Manufacturers - Specialty & Generic Quick infos Headquarters: Hyderabad, India Trade prices Volume: Market Cap: 9.27B Prev closed: 42.35 Open: 42.35 High: 42.56 Low: 41.85 52 week low: 34.67 52 week high: 42.91 Dividends: Next ER: May 18, 2023 Before Market Opens
About the Company Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad, Telangana, India. The company was founded by Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited, of Hyderabad, India.
Earnings History Date EPS / Forecast Revenue / Forecast July 27, 2023 May 10, 2023 -0.28 / 0.61767.96M / 742.49MBeat! January 25, 2023 0.91 / 0.68818M / 728.51MBeat! October 27, 2022 0.8111 / 0.5645764.59M / 695.5MBeat! July 27, 2022 0.8952 / 0.5112653.93M / 679.18Mview more
NYSE - New York Stock Exchange
More profiles and info about the company Founded:1984 Employees:21,966 News
Journey Medical Corporation Enters into a Definitive Agreement with Dr. Reddys Laboratories Ltd. to Develop and Commercialize DFD-29 for the Treatment of Rosacea finance.yahoo.com Mar 20, 2023 8:00 am
Eton Pharmaceuticals Announces Sale of Hospital Products finance.yahoo.com Mar 20, 2023 7:30 am Five Indian drugmakers to jointly start trial of Merck & Co's COVID-19 drug finance.yahoo.com Mar 20, 2023 7:27 am
Coya Therapeutics, Inc. Announces an Agreement with Dr. Reddys Laboratories, Ltd. to License its proposed biosimilar Abatacept for the Development and Commercialization of COYA 302 for the Treatment of Neurodegenerative Diseases finance.yahoo.com Mar 20, 2023 7:00 am
Dr. Reddy's Laboratories Announces Agreement to Acquire Mayne Pharmas U.S. Generic Prescription Product Portfolio finance.yahoo.com Mar 20, 2023 6:00 am
Dr. Reddy's Laboratories Announces the Launch of Valsartan Tablets, USP in the U.S. Market finance.yahoo.com Mar 20, 2023 3:18 am
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY finance.yahoo.com Mar 20, 2023 12:35 am
Dr. Reddy's (RDY) Q3 Earnings & Revenues Beat Estimates finance.yahoo.com Jan 27, 2023 1:36 pm
Dr. Reddys Laboratories Limited (NYSE:RDY) Q3 2023 Earnings Call Transcript finance.yahoo.com Jan 26, 2023 12:55 pm
Dr. Reddy's Laboratories enters into a licensing agreement with Slayback Pharma to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify® in the U.S. finance.yahoo.com Nov 15, 2022 1:24 pm
Dr. Reddy's Lab, Fortress Biotech Ink DFD-29 Collaboration Pact For Chronic Skin Disorder finance.yahoo.com Nov 15, 2022 11:29 am
Dr. Reddy's (RDY) Q3 Earnings Decline Y/Y, Sales Increase finance.yahoo.com Nov 15, 2022 10:25 am
Intercept Settles Ocaliva Litigation With Reddy's Lab finance.yahoo.com Aug 17, 2022 10:16 am
Dr. Reddy's (RDY) Q1 Earnings Increase Y/Y, Sales Increase finance.yahoo.com Jul 29, 2022 4:28 pm
Dr. Reddy's Laboratories Gets Emergency Use Authorisation for Sputnik V in India finance.yahoo.com Mar 20, 2023 2:03 am
Dr. Reddy's Laboratories Announces the Launch of Lansoprazole DR Orally Disintegrating Tablets in the U.S. Market finance.yahoo.com Mar 20, 2023 1:13 am
Dr. Reddys Successfully Completes Phase 1 Study of DRL_TC, a Proposed Biosimilar of Tocilizumab finance.yahoo.com Dec 19, 2022 8:00 am
ARGA Investment Management, LP Buys Petroleo Brasileiro SA Petrobras, Trip. ... finance.yahoo.com Nov 15, 2022 9:38 am
Dr. Reddy's Laboratories Announces the Acquisition of an Injectable Product Portfolio from Eton Pharma finance.yahoo.com Nov 15, 2022 9:09 am
AMETEK Announces Appointment of Karleen Oberton to Board of Directors finance.yahoo.com Nov 15, 2022 8:00 am RDY Dividends Ex-Dividend Amount Announced Date Record Date Payment Date Jul 8, 2022 0.3247258 Jan 1, 1970 Jul 8, 2021 0.2797405 Aug 11, 2021 Jul 10, 2020 0.27696 Aug 17, 2020 Jul 12, 2019 0.2871 Jan 1, 1970 Jul 13, 2018 0.6059 Aug 9, 2018 view more
Key Persons CEO : G. V. Prasad (2001–) Talk about Dr. Reddy's Laboratories Ltd below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis